Increased parathyroid hormone is associated with higher fasting glucose in individuals with normocalcemic primary hyperparathyroidism and prediabetes: A pilot study
Primary hyperparathyroidism (PHPT) is characterized by hypercalcemia and concentrations of parathyroid hormone (PTH) that are inappropriately high for the hypercalcemic state [1]. Accumulating evidence suggests an increased prevalence of metabolic disorders, including Impaired Glucose Tolerance (IGT) and Type 2 Diabetes, among patients with PHPT [2]. In addition, amelioration of glucose intolerance and insulin resistance has been documented in individuals with PHPT following successful parathyroidectomy [3 –8].
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Spyridon N. Karras, Theocharis Koufakis, Xanthippi Tsekmekidou, Vassiliki Antonopoulou, Pantelis Zebekakis, Kalliopi Kotsa Source Type: research
More News: Diabetes | Diabetes Type 2 | Endocrinology | Hormones | Hyperparathyroidism | Insulin | Parathyroidectomy | Study